Ratings by Berenberg (Esther Hong)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/25/2022 | Aprea | APRE | Maintain | Buy (N/A) |
|
Details | ||
| 5/23/2022 | Concert Pharmaceuticals | CNCE | Maintain | Buy (N/A) |
|
Details | ||
| 5/20/2022 | Spero Therapeutics | SPRO | Downgrade | Hold (Buy) |
1.44 (1.00) |
-30.56% | Details | |
| 4/21/2022 | Athira Pharma | ATHA | New Coverage | Buy (N/A) |
11.63 (3.77) |
-67.58% | Details | |
| 1/10/2022 | Bionomics Ltd. | BNOX | New Coverage | Buy (N/A) |
11.55 (7.86) |
-31.95% | Details | |
| 8/16/2021 | Invitation Homes | INVH | Downgrade | Hold (Buy) |
39.62 (38.73) |
-2.25% | Details | |
| 8/16/2021 | Aprea | APRE | Downgrade | Hold (Buy) |
3.65 (0.88) |
-75.89% | Details | |
| 8/16/2021 | American Homes 4 Rent | AMH | Downgrade | Hold (Buy) |
40.96 (37.62) |
-8.15% | Details | |
| 6/10/2021 | Acadia Pharmaceuticals | ACAD | New Coverage | Hold (N/A) |
26.13 (16.88) |
-35.4% | Details | |
| 6/10/2021 | Axsome Therapeutics | AXSM | New Coverage | Buy (N/A) |
63.50 (59.34) |
-6.55% | Details | |
| 12/16/2020 | Concert Pharmaceuticals | CNCE | New Coverage | Buy (N/A) |
12.79 (6.77) |
-47.07% | Details | |
| 12/16/2020 | Spero Therapeutics | SPRO | New Coverage | Buy (N/A) |
17.40 (1.00) |
-94.25% | Details | |
| 12/16/2020 | Aldeyra Therapeutics | ALDX | New Coverage | Buy (N/A) |
6.89 (6.98) |
1.31% | Details | |
| 12/16/2020 | Aprea | APRE | New Coverage | Buy (N/A) |
29.73 (0.88) |
-97.04% | Details |
